J&J MedTech announced it will spin off its orthopedics business into a stand alone company called DePuy Synthes within the next two years.
The Numbers
Five things we’re watching as the orthopedic market’s competitive landscape evolves and we move into the second half of 2025.
Our chart of the month tracks spine M&A activity over the last decade, including the seven deals done so far in 2025.
Orthoflash®
The Phase 3 trial is evaluating the single-injection biologic candidate for improvements in pain and function.
October 16, 2025
,
ANTHEM Elbow is designed to offer surgeons anatomically-contoured plates to treat a variety of fractures, regardless of severity or complexity,
October 15, 2025
,
The prodisc C Vivo and prodisc C SK are now indicated for reconstruction of a vertebral disc from C3-C7 following discectomy at one level or two contiguous levels.
October 14, 2025
,
The total shoulder replacement system is designed for tissue-sparing surgery, providing same day post-op mobility.
October 13, 2025
,
Surgical Theater has received FDA 510(k) clearance for the next-generation release of its spine platform, SyncAR Spine.
October 10, 2025
,
Competitive Landscape
ORTHOWORLD Experts talk you through market forecasts, company sales and key trends.
Industry Voices
